RAP 0.00% 20.5¢ raptor resources limited

Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-29

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 86 Posts.
    lightbulb Created with Sketch. 120
    Good announcement. Win win for so many areas.
    I wonder if this real world use case, it's data gathered and experience realised for all will help with evidence to respond to ongoing FDA denovo discussions?
    Last edited by Maltsy: 11/05/20
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.